Melanotan II
Animal / preclinicalAlso known as: MT-2, MT-II
Community-reported ranges are anecdotal and not clinically validated. Evidence grade shown reflects the strength of available human data. Not a prescription. Legal status varies by country and changes over time; verify locally.
Overview
A melanocortin-receptor agonist used for tanning. Carries notable safety concerns and tightening legal status; strongly cautioned.
Mechanism
Non-selective melanocortin-receptor agonist increasing melanogenesis.
Evidence
Poorly characterised safety; associated with adverse events. Not recommended.
Community-reported information
Not shown. Safety concerns and tightening regulation make community ranges inappropriate to present.
General information only, not tailored to you and not a recommendation. Some regions withhold this entirely.
Half-life
Not well characterised.
Storage
Refrigerate.
Commonly reported side effects
- Nausea
- Flushing
- Darkening of moles
- Blood-pressure changes
Legal status by region
- USNot FDA-approved; sale for human use unlawful.
- GBNot licensed; MHRA has warned against use.
- AUSchedule 9 (prohibited substance) since Feb 2026.
Legal status changes over time; verify locally before relying on this.
Citations
- Melanotan safety reportsPubMed